
<p><strong>New Delhi: </strong><span style="font-weight: 400;">The United States is all set to roll out Covid-19 vaccination for children aged 5 to 11 years, with the director of the US Centers for Disease Control and Prevention (CDC) Tuesday recommending paediatric Covid vaccine for the age group.</span></p> <p><span style="font-weight: 400;">This announcement came hours after outside advisers to the CDC unanimously backed the move, saying the vaccine’s benefits outweigh the risks, and days after the US Food and Drug Administration authorised Pfizer-BioNTech Covid-19 vaccine for young children. </span></p> <p><span style="font-weight: 400;">While the shot given to those aged 12 and older is 30 micrograms, the FDA authorised a 10-microgram dose in the young children, media reports said. </span></p> <p><span style="font-weight: 400;">Pfizer and BioNTech claim their vaccine showed 90.7 per cent efficacy in a clinical trial of the drug in children aged 5 to 11, according to reports. </span></p> <p><span style="font-weight: 400;">In a statement, CDC Director Rochelle Walensky said: "We know millions of parents are eager to get their children vaccinated and with this decision, we now have recommended that about 28 million children receive a COVID-19 vaccine."</span></p> <p><span style="font-weight: 400;">"The vote was unanimous because the evidence is so clear. Kids 5 to 11 are better off vaccinated," Ashish Jha, dean of the Brown University School of Public Health, who was not a member of the CDC panel, said on Twitter after the vote.</span></p> <blockquote class="twitter-tweet"> <p dir="ltr" lang="en">CDC's vaccine expert advisory committee voted<br /><br />14 to 0<br /><br />in favor of vaccinating all kids ages 5 to 11<br /><br />These are our nation's leading physicians and scientists<br /><br />Most are also parents<br /><br />The vote was unanimous because the evidence is so clear<br /><br />Kids 5 to 11 are better off vaccinated</p> — Ashish K. Jha, MD, MPH (@ashishkjha) <a href="https://twitter.com/ashishkjha/status/1455642962952605702?ref_src=twsrc%5Etfw">November 2, 2021</a></blockquote> <p> <script src="https://platform.twitter.com/widgets.js" async="" charset="utf-8"></script> </p> <p><span style="font-weight: 400;">President Joe Biden called the authorisation a turning point in the battle against the pandemic.</span></p> <p><span style="font-weight: 400;">“The program will ramp up over the coming days, and fully up and running during the week of November 8,” Biden said in a statement. </span><span style="font-weight: 400;">He said “thousands of pharmacies, pediatrician’s offices, schools, and other sites” would be equipped to vaccinate children.</span></p> <h3><strong>'A Herculean effort'</strong></h3> <p><span style="font-weight: 400;">The US government and Pfizer have started distributing the vaccine for a widespread rollout for children.</span></p> <p><span style="font-weight: 400;">"We've shipped to dozens of states already over the weekend and Monday. There is a Herculean effort so there will be doses available everywhere," a Reuters report quoted Pfizer Chief Executive Albert Bourla as saying in an interview. </span></p> <p><span style="font-weight: 400;">In India, the subject expert committee (SEC) of the Drug Controller General of India (DCGI) recently recommended emergency use of Covaxin to inoculate children aged 2-18 years against the coronavirus (SARS-CoV-2).</span></p> <p><span style="font-weight: 400;">While Bharat Biotech, which makes the vaccine, has submitted data from phase 3 trials of the drug, involving children, a final nod from the DCGI is awaiting.</span></p> <p><span style="font-weight: 400;">According to reports, the Bharat Biotech data showed the efficacy rate of the Covaxin shot among children at 77.8 per cent, similar to that among adults.</span></p>
No comments:
Post a Comment